Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A laboratory test identified by CPT® Code 82649 is utilized to measure the concentration of dihydromorphinone in the bloodstream. Dihydromorphinone is a highly potent narcotic analgesic, which is a type of medication used to relieve pain. It is derived from a hydrogenated ketone of morphine, making it chemically related to this well-known opioid. This medication is typically prescribed for individuals experiencing moderate to severe pain, providing significant relief in various clinical scenarios. Dihydromorphinone can be administered in different ways, including oral ingestion or through injection, depending on the patient's needs and the clinical setting. It is important to note that dihydromorphinone may be marketed under the brand name Dilaudid, which is recognized in the pharmaceutical industry. To perform this test, a blood sample is collected through a procedure known as venipuncture, which is separately reportable. The primary objective of this laboratory test is to quantify the amount of dihydromorphinone present in the blood, aiding healthcare providers in monitoring therapeutic levels and ensuring patient safety during treatment.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test for dihydromorphinone, coded as CPT® 82649, is indicated for the following conditions:
The procedure for testing dihydromorphinone involves several key steps that ensure accurate measurement of the drug's concentration in the blood.
After the procedure, patients may experience minimal discomfort at the venipuncture site, which typically resolves quickly. There are generally no specific post-procedure care instructions required for this test, but patients should be advised to monitor the site for any unusual symptoms, such as excessive bleeding or signs of infection. The results of the dihydromorphinone test will be communicated to the prescribing physician, who will interpret the findings in the context of the patient's overall treatment plan and pain management strategy.
| Short Descr | ASSAY OF DIHYDROMORPHINONE | Medium Descr | ASSAY OF DIHYDROMORPHINONE | Long Descr | Dihydromorphinone | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Deleted | Code deleted, see 80361 |
| 2013-01-01 | Changed | Medium Descriptor changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.